FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称DAZOSTINAG
异名/同义词7-DEAZAINOSINE, (P(R))-2'-DEOXY-2'-FLUORO-5'-O-((R)-HYDROXYMERCAPTOPHOSPHINYL)-P-THIOADENYLYL-(3'->5')-7-FLUORO-, CYCLIC (2'->5')-NUCLEOTIDE
CYCLO((P3'R)-2'-DEOXY-2'-FLUORO-P-THIOADENYLYL-(3'->5')-(P2'R)-7-FLUORO-P-THIO-7-DEAZAINOSINYL-(2'->5'))
DAZOSTINAG
DAZOSTINAG [INN]
DAZOSTINAG [USAN]
TAK-676
CAS登记号2553413-86-6
物质唯一标识(Unique Ingredient Identifier)W4RT71M1YD
分子式C21H22F2N8O10P2S2
国际化合物标识(International Chemical Identifier,InChI)SIIGKCBSQKWSLM-RNPBXGGWSA-N
SMILESO[C@H]1[C@@H]2[C@@H](O[C@@H]1CO[P@@](=O)(S)O[C@@H]3[C@@H](CO[P@@](=O)(S)O2)O[C@H]([C@@H]3F)n4c5c(nc4)c(N)ncn5)n6c7c(c(F)c6)c(=O)nc[nH]7
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System